Thank you, Dan and good morning everyone. We reported revenue of $29.2 million for the third quarter a decrease of $91.5 million compared to the same quarter in 2014. Revenue for the nine-month period of 2015 was $260.3 million a decrease of $130.2 million in the same period in 2014. The timing of customer orders affected revenue in the third quarter, but as Dan mentioned, our annual outlook has not changed and we expect to generate approximately 40% of our annual revenue in the fourth quarter. As a reminder, we recognize revenue for the LEU business segment at the time product is delivered under the terms of customer contracts and a relatively small change in the timing of customer orders due to a change in the customers; refueling schedule may cause operating results to be substantially above or below expectations. The volume of SWU sales declined 88% and 58% in the three and nine-month periods of 2015 compared to 2014 reflecting this variability in timing of utility customer orders as well as the expected decline in SWU deliveries in 2015. The average price billed to customers for sales of SWU declined 24% in the three-month period and increased 6% in the nine-month period compared to 2014 reflecting the particular contracts under which SWU were sold during the periods. Cost of sales for the third quarter was $53.6 million a decrease of $72.5 million compared to the corresponding period in 2014 due to the lowest SWU sales volumes partially offset by higher direct charges. For the nine-month period of 2015 cost of sales was $273.5 million a reduction of $139.8 million compared to the same period in 2014 due to lower SWU sales volumes and lower direct charges partially offset by higher Uranium sales volumes and higher costs in the Contract Services segment commensurate with higher revenue. Since ceasing Uranium enrichment at the Paducah GDP in May 2013, we have incurred a number of expenses unrelated to production that have been charged directly to cost of sales. These charges totaled $23.9 million in the third quarter and $32.5 million in the nine months ended September 30, 2015, and $17.5 million and $66.7 million in the corresponding periods in 2014. These included a direct charge of $21.6 million resulting from our re-measurement of pension obligations on September 30, 2015. Lump sum pension payments in the first nine months of 2015 to former employees including those affected by workforce reductions resulted in an interim re-measurement under settlement accounting rules. Another re-measurement of the plans will be made on December 31. Effective with the adoption of Fresh Start accounting as of September 30, 2014 Centrus immediately recognizes actuarial gains and losses in the statement of operations in the period in which they arise. The interim re-measurement also resulted in $3.2 million charged to selling, general and administrative expenses in the third quarter of 2015. The Contract Services segment includes revenue in cost of sales for American Centrifuge work we performed under the Act II agreement as a subcontractor to UT-Battelle and Oak Ridge National Laboratory. As we reported in September, Oak Ridge National Labs informed us the DoE had decided to reduce funding for the American Centrifuge Program and therefore Oak Ridge National Labs intended the contract with us at a reduced level for the period through September 30, 2016 with the possibility for additional extensions. We have been in discussions with DoE concerning of obtaining additional funding to permit our operations at Piketon to continue, but we have no assurance that additional funding will be provided. As a result of DoE's decision we notified our American Centrifuge employees of possible layoffs. Based on the level of funding reduction we incurred a special charge of $8.7 million in the third quarter of 2015 for estimated termination benefits consisting primarily of payments under our severance plan. We expect to make payments for these workforce reductions over the next 18 months. Should funding not be restored for operations at the Piketon, Ohio facility, we could incur further costs associated with the reduction in scope, these costs could commence in the fourth quarter of 2015 as the Piketon workforce shifted to demobilization efforts and could extend into 2016. Demobilization costs have been incurred related to prior limited reductions in scope and are included in advanced technology cost. We currently estimate that we could incur demobilization costs of approximately $10 million to $15 million in the fourth quarter of 2015. This estimate is in addition to the severance costs charged in the third quarter of 2015. We had a gross loss of $24.4 million in the third quarter and $13.2 million for the nine-month period partially reflecting the pension re-measurement mentioned earlier. Americans Centrifuge costs incurred by the Company that are outside of the agreement with Oak Ridge National Labs which ended on September 30, 2015 are included in advanced technology costs, including certain demobilization and maintenance costs. Such costs totaled $1.9 million in the three months and $7.7 [ph] million in the nine months ended September 30, 2015 and $5.3 million in the three months and $12.3 million in the nine months ended September 30, 2014. Selling, general and administrative expense increased by $3.1 million in the three-month period compared to 2014 due to the pension re-measurement loss described earlier, but decreased by $0.1 million in the nine-month period compared to the prior year. Centrus reported a net loss for the third quarter of $55.1 million compared to a net income of $418.9 million in the same quarter of 2014. For the nine-month period ended September 30, 2015 we reported a net loss of $85.6 million compared to a net income of $340.1 million in the same period last year. The results reflect net reorganization gains of $426.9 million in the prior nine-month period, amortization in the current periods of intangible assets that resulted from our re-organization and an increase on our gross loss in the three-month period, partially offset by declines in advanced technology costs and a decline in our gross loss in the nine-month period. Turning to cash we reported a cash balance of $180.3 million at September 30, 2015. The sources and uses of cash flow in the nine-month period were in line with our expectations. As mentioned earlier, we are reiterating our guidance for 2015 that we expect total revenue in the range of $425 to $450 million and an end of year cash balance in a range of $175 to $200 million. That concludes the remarks for today's call. Now I would like to turn it over to the operator for any questions.